Target intelligence / Profile preview

Delta-like Protein 1 Homolog

Molecular classification
Transmembrane protein, Ligand, NOTCH ligand, Growth factor
01

Overview

Delta-like protein 1 homolog refers to DLL1 (Delta-like canonical Notch ligand 1) and DLK1 (Delta-like non-canonical Notch ligand 1). Both are members of the delta/serrate/jagged family involved in Notch signaling. DLL1 is a canonical ligand that activates Notch receptors, influencing development, neurogenesis, and immune function. DLK1 is a non-canonical ligand that modulates Notch signaling, inhibiting adipogenesis and regulating muscle development. They are implicated in various diseases, making them potential therapeutic targets but require careful consideration due to their developmental roles.

Other names
DLL1Delta-like canonical Notch ligand 1DeltaDelta-Notch ligandDllDLK1Delta-like non-canonical Notch ligand 1FA1PREF-1Pref-1ZOGpG2Fetal antigen 1preadipocyte factor 1
02

Mechanism of action

DLL1: Activates Notch receptors. DLK1: Modulates/inhibits Notch receptors.

03

Biological functions

Notch signaling pathway modulationCell fate determinationSomite formationLeft-right asymmetry determinationNeurogenesisT-cell differentiationB-cell differentiationAdipogenesis inhibitionSkeletal muscle developmentPlacental formation
04

Disease associations

Neurodevelopmental disordersCongenital anomaliesAdipose tissue disordersMuscle developmental defects
05

Safety considerations

Potential for developmental defects if targeted during pregnancy.Complex effects on cell fate decisions could lead to unintended consequences in regenerative medicine or cancer therapy.

Beyond the preview

Go deeper on Delta-like Protein 1 Homolog.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Delta-like Protein 1 Homolog.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call